Skip to content

Beverage Consumption and Fine Motor Control

The Effect of Low Calorie Sweetener Consumption on Body Weight, Body Composition, Appetite, and Energy Intake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02928653
Acronym
LCS
Enrollment
187
Registered
2016-10-10
Start date
2015-12-31
Completion date
2018-12-31
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight

Keywords

energy intake, energy expenditure, appetite

Brief summary

The aim of this study will be to compare the effects of daily consumption of aspartame, rebaudioside a, saccharin, sucralose, and sucrose on body weight and composition in a standardized protocol. The investigators hypothesize that individual low calorie sweeteners (consumed in a beverage) differ from each other in promoting weight loss and decreased fat mass (without energy restriction or dietary guidance) based on their chemical structure.

Interventions

DIETARY_SUPPLEMENTBeverage

Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks

Sponsors

Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 25-40 kg/M2 * Non or rare users of LCS * Willing to consume large volumes of beverages daily

Exclusion criteria

* Weight change \> 3kg in the last year * Plan to initiate a new diet plan in the next 6 months * Exhibit eating restraint * Pregnant/lactating

Design outcomes

Primary

MeasureTime frameDescription
Body Weight12 weeks
Body Composition12 weeksDuel emission X-ray absorbtiometry
Energy Intake12 weeks24 hr Dietary Recall
Appetite12 weeks24 hr visual analog scale appetite
Energy Expenditure12 weeksaccelerometer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026